Amyloid Inhibitors: Lysine-Derived Carbon Dots for Chiral Inhibition of Prion Peptide Fibril Assembly (Adv. Therap. 4/2018)

Advanced Therapeutics- United Kingdom

doi 10.1002/adtp.201870008

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Masthead (Adv. Therap. 4/2018)

Advanced Therapeutics
BiochemistryMedicineGeneticsPharmacologyPharmaceutical Science
2018English

Masthead (Adv. Therap. 8/2018)

Advanced Therapeutics
BiochemistryMedicineGeneticsPharmacologyPharmaceutical Science
2018English

Masthead (Adv. Therap. 3/2018)

Advanced Therapeutics
BiochemistryMedicineGeneticsPharmacologyPharmaceutical Science
2018English

Masthead (Adv. Therap. 7/2018)

Advanced Therapeutics
BiochemistryMedicineGeneticsPharmacologyPharmaceutical Science
2018English

Masthead (Adv. Therap. 4/2019)

Advanced Therapeutics
BiochemistryMedicineGeneticsPharmacologyPharmaceutical Science
2019English

Probing Peptide Domains Implicated in Amyloid Fibril Formation During Amelogenin Nanoribbon Assembly

Biophysical Journal
Biophysics
2018English

Inhibition of Alzheimer Β-Peptide Fibril Formation by Serum Amyloid P Component

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Human Anti-Prion Antibodies Block Prion Peptide Fibril Formation and Neurotoxicity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Inhibition of A-Synuclein Amyloid Fibril Elongation by Blocking Fibril Ends

Biophysical Journal
Biophysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy